Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this issue...
Drug safety advice
- Nitrous oxide: neurological and haematological toxic effects, especially with prolonged use
- Rituximab and efalizumab: progressive multifocal leukoencephalopathy
Yellow Card scheme update
- Highlights of 2008
End of year quiz
- Test your drug safety knowledge
Stop Press
- Conventional (typical) antipsychotics: increased mortality in dementia
- Prograf and Advagraf (tacrolimus): serious medication errors
- Norfloxacin: restricted use in urinary infections
- Hedrin: keep treated hair away from sources of fire
- Melanotan: an unlicensed medicine, the risks of which are unknown
- Tigecycline reformulation affects compatibility: correction
Other information from the MHRA
- Patient Information Leaflets of the month: sertraline, Molipaxin, and amisulpiride
Drug Safety Update: Volume 2 Issue 5, December 2008 
